Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland

To assess the contemporaneous prevalence of diabetic peripheral neuropathy (DPN) in people with type 1 diabetes (T1D) in Scotland and study its cross-sectional association with risk factors and other diabetic complications. We analyzed data from a large representative sample of adults with T1D ( = 5...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2020-04, Vol.43 (4), p.734-742
Hauptverfasser: Jeyam, Anita, McGurnaghan, Stuart J, Blackbourn, Luke A K, McKnight, John M, Green, Fiona, Collier, Andrew, McKeigue, Paul M, Colhoun, Helen M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 742
container_issue 4
container_start_page 734
container_title Diabetes care
container_volume 43
creator Jeyam, Anita
McGurnaghan, Stuart J
Blackbourn, Luke A K
McKnight, John M
Green, Fiona
Collier, Andrew
McKeigue, Paul M
Colhoun, Helen M
description To assess the contemporaneous prevalence of diabetic peripheral neuropathy (DPN) in people with type 1 diabetes (T1D) in Scotland and study its cross-sectional association with risk factors and other diabetic complications. We analyzed data from a large representative sample of adults with T1D ( = 5,558). We assessed the presence of symptomatic neuropathy using the dichotomized (≥4) Michigan Neuropathy Screening Instrument Patient Questionnaire score. Logistic regression models were used to investigate associations between DPN and risk factors, as well as with other complications. The burden of DPN is substantial with 13% prevalence overall. Adjusting for attained age, diabetes duration, and sex, the odds of DPN increased mainly with waist-to-hip ratio, lipids, poor glycemic control (odds ratio 1.51 [95% CI 1.21-1.89] for levels of 75 vs. 53 mmol/mol), ever versus never smoking (1.67 [1.37-2.03]), and worse renal function (1.96 [1.03-3.74] for estimated glomerular filtration rate levels
doi_str_mv 10.2337/dc19-1582
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2344278696</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2387484234</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-123c86bafa9ed207cde9dc1f2d85e7a9dffc1ae292a375cbcfe79ff47d63acc03</originalsourceid><addsrcrecordid>eNpdkctu1TAQhi0EoofCghdAlti0i4BvObHZHVp6kSqoOEUsI8eetK6SOPhSKS_G89VHp2XBajSab_5_ND9C7yn5xDhvPltDVUVryV6gFVW8rupayJdoRahQVa0UO0BvYrwnhAgh5Wt0wKlqBCVkhf6eOt1BcgZ_hxz8rNPdgi8j1nibu5j0lJwe8NccLEzYTfga_DwA_u3SHb5ZZsAU7xWg7Ex2t7pNwU-3w4I3MXrjdAK757el82D85Mfid-qitg_FQN_CF7zB137Og07OT9VPmANEKKPkHqAIZrvgs-BHvDU-DcXnLXrV6yHCu6d6iH6dfbs5uaiufpxfnmyuKsOFTBVl3Mh1p3utwDLSGAuqPKtnVtbQaGX73lANTDHNm9p0podG9b1o7JprYwg_REd73Tn4PxliakcXDQzlBvA5towLwRq5VuuCfvwPvfc5TOW6QslGSFHgQh3vKRN8jAH6dg5u1GFpKWl3Yba7MNtdmIX98KSYuxHsP_I5Pf4I4pmdlQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2387484234</pqid></control><display><type>article</type><title>Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Jeyam, Anita ; McGurnaghan, Stuart J ; Blackbourn, Luke A K ; McKnight, John M ; Green, Fiona ; Collier, Andrew ; McKeigue, Paul M ; Colhoun, Helen M</creator><creatorcontrib>Jeyam, Anita ; McGurnaghan, Stuart J ; Blackbourn, Luke A K ; McKnight, John M ; Green, Fiona ; Collier, Andrew ; McKeigue, Paul M ; Colhoun, Helen M ; SDRNT1BIO Investigators</creatorcontrib><description>To assess the contemporaneous prevalence of diabetic peripheral neuropathy (DPN) in people with type 1 diabetes (T1D) in Scotland and study its cross-sectional association with risk factors and other diabetic complications. We analyzed data from a large representative sample of adults with T1D ( = 5,558). We assessed the presence of symptomatic neuropathy using the dichotomized (≥4) Michigan Neuropathy Screening Instrument Patient Questionnaire score. Logistic regression models were used to investigate associations between DPN and risk factors, as well as with other complications. The burden of DPN is substantial with 13% prevalence overall. Adjusting for attained age, diabetes duration, and sex, the odds of DPN increased mainly with waist-to-hip ratio, lipids, poor glycemic control (odds ratio 1.51 [95% CI 1.21-1.89] for levels of 75 vs. 53 mmol/mol), ever versus never smoking (1.67 [1.37-2.03]), and worse renal function (1.96 [1.03-3.74] for estimated glomerular filtration rate levels &lt;30 vs. ≥90 mL/min/1.73 m ). The odds significantly decreased with higher HDL cholesterol (0.77 [0.66-0.89] per mmol/L). Living in more deprived areas was associated with DPN (2.17 [1.78-2.65]) for more versus less deprived areas adjusted for other risk factors. Finally, individuals with prevalent DPN were much more likely than others to have other diabetes complications. Diabetic neuropathy remains substantial, particularly affecting those in the most socioeconomically deprived groups. Those with clinically manifest neuropathy also have a higher burden of other complications and elevated levels of modifiable risk factors. These data suggest that there is considerable scope to reduce neuropathy rates and narrow the socioeconomic differential by better risk factor control.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc19-1582</identifier><identifier>PMID: 31974100</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Adolescent ; Adult ; Cholesterol ; Complications ; Cross-Sectional Studies ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (insulin dependent) ; Diabetes Mellitus, Type 1 - complications ; Diabetes Mellitus, Type 1 - epidemiology ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetic Neuropathies - epidemiology ; Diabetic Neuropathies - etiology ; Diabetic neuropathy ; Female ; Glomerular filtration rate ; Glucose monitoring ; Health risk assessment ; High density lipoprotein ; Hip ; Humans ; Lipids ; Male ; Middle Aged ; Peripheral neuropathy ; Population studies ; Prevalence ; Regression analysis ; Regression models ; Renal function ; Research design ; Risk analysis ; Risk Factors ; Risk management ; Scotland - epidemiology ; Socio-economic aspects ; Socioeconomic Factors ; Socioeconomics ; Vulnerable Populations - statistics &amp; numerical data ; Young Adult</subject><ispartof>Diabetes care, 2020-04, Vol.43 (4), p.734-742</ispartof><rights>2020 by the American Diabetes Association.</rights><rights>Copyright American Diabetes Association Apr 1, 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c348t-123c86bafa9ed207cde9dc1f2d85e7a9dffc1ae292a375cbcfe79ff47d63acc03</citedby><cites>FETCH-LOGICAL-c348t-123c86bafa9ed207cde9dc1f2d85e7a9dffc1ae292a375cbcfe79ff47d63acc03</cites><orcidid>0000-0001-5220-6244 ; 0000-0001-8701-0233 ; 0000-0002-8345-3288</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31974100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jeyam, Anita</creatorcontrib><creatorcontrib>McGurnaghan, Stuart J</creatorcontrib><creatorcontrib>Blackbourn, Luke A K</creatorcontrib><creatorcontrib>McKnight, John M</creatorcontrib><creatorcontrib>Green, Fiona</creatorcontrib><creatorcontrib>Collier, Andrew</creatorcontrib><creatorcontrib>McKeigue, Paul M</creatorcontrib><creatorcontrib>Colhoun, Helen M</creatorcontrib><creatorcontrib>SDRNT1BIO Investigators</creatorcontrib><title>Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>To assess the contemporaneous prevalence of diabetic peripheral neuropathy (DPN) in people with type 1 diabetes (T1D) in Scotland and study its cross-sectional association with risk factors and other diabetic complications. We analyzed data from a large representative sample of adults with T1D ( = 5,558). We assessed the presence of symptomatic neuropathy using the dichotomized (≥4) Michigan Neuropathy Screening Instrument Patient Questionnaire score. Logistic regression models were used to investigate associations between DPN and risk factors, as well as with other complications. The burden of DPN is substantial with 13% prevalence overall. Adjusting for attained age, diabetes duration, and sex, the odds of DPN increased mainly with waist-to-hip ratio, lipids, poor glycemic control (odds ratio 1.51 [95% CI 1.21-1.89] for levels of 75 vs. 53 mmol/mol), ever versus never smoking (1.67 [1.37-2.03]), and worse renal function (1.96 [1.03-3.74] for estimated glomerular filtration rate levels &lt;30 vs. ≥90 mL/min/1.73 m ). The odds significantly decreased with higher HDL cholesterol (0.77 [0.66-0.89] per mmol/L). Living in more deprived areas was associated with DPN (2.17 [1.78-2.65]) for more versus less deprived areas adjusted for other risk factors. Finally, individuals with prevalent DPN were much more likely than others to have other diabetes complications. Diabetic neuropathy remains substantial, particularly affecting those in the most socioeconomically deprived groups. Those with clinically manifest neuropathy also have a higher burden of other complications and elevated levels of modifiable risk factors. These data suggest that there is considerable scope to reduce neuropathy rates and narrow the socioeconomic differential by better risk factor control.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Cholesterol</subject><subject>Complications</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (insulin dependent)</subject><subject>Diabetes Mellitus, Type 1 - complications</subject><subject>Diabetes Mellitus, Type 1 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetic Neuropathies - epidemiology</subject><subject>Diabetic Neuropathies - etiology</subject><subject>Diabetic neuropathy</subject><subject>Female</subject><subject>Glomerular filtration rate</subject><subject>Glucose monitoring</subject><subject>Health risk assessment</subject><subject>High density lipoprotein</subject><subject>Hip</subject><subject>Humans</subject><subject>Lipids</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Peripheral neuropathy</subject><subject>Population studies</subject><subject>Prevalence</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Renal function</subject><subject>Research design</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Risk management</subject><subject>Scotland - epidemiology</subject><subject>Socio-economic aspects</subject><subject>Socioeconomic Factors</subject><subject>Socioeconomics</subject><subject>Vulnerable Populations - statistics &amp; numerical data</subject><subject>Young Adult</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkctu1TAQhi0EoofCghdAlti0i4BvObHZHVp6kSqoOEUsI8eetK6SOPhSKS_G89VHp2XBajSab_5_ND9C7yn5xDhvPltDVUVryV6gFVW8rupayJdoRahQVa0UO0BvYrwnhAgh5Wt0wKlqBCVkhf6eOt1BcgZ_hxz8rNPdgi8j1nibu5j0lJwe8NccLEzYTfga_DwA_u3SHb5ZZsAU7xWg7Ex2t7pNwU-3w4I3MXrjdAK757el82D85Mfid-qitg_FQN_CF7zB137Og07OT9VPmANEKKPkHqAIZrvgs-BHvDU-DcXnLXrV6yHCu6d6iH6dfbs5uaiufpxfnmyuKsOFTBVl3Mh1p3utwDLSGAuqPKtnVtbQaGX73lANTDHNm9p0podG9b1o7JprYwg_REd73Tn4PxliakcXDQzlBvA5towLwRq5VuuCfvwPvfc5TOW6QslGSFHgQh3vKRN8jAH6dg5u1GFpKWl3Yba7MNtdmIX98KSYuxHsP_I5Pf4I4pmdlQ</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Jeyam, Anita</creator><creator>McGurnaghan, Stuart J</creator><creator>Blackbourn, Luke A K</creator><creator>McKnight, John M</creator><creator>Green, Fiona</creator><creator>Collier, Andrew</creator><creator>McKeigue, Paul M</creator><creator>Colhoun, Helen M</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5220-6244</orcidid><orcidid>https://orcid.org/0000-0001-8701-0233</orcidid><orcidid>https://orcid.org/0000-0002-8345-3288</orcidid></search><sort><creationdate>202004</creationdate><title>Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland</title><author>Jeyam, Anita ; McGurnaghan, Stuart J ; Blackbourn, Luke A K ; McKnight, John M ; Green, Fiona ; Collier, Andrew ; McKeigue, Paul M ; Colhoun, Helen M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-123c86bafa9ed207cde9dc1f2d85e7a9dffc1ae292a375cbcfe79ff47d63acc03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Cholesterol</topic><topic>Complications</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (insulin dependent)</topic><topic>Diabetes Mellitus, Type 1 - complications</topic><topic>Diabetes Mellitus, Type 1 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetic Neuropathies - epidemiology</topic><topic>Diabetic Neuropathies - etiology</topic><topic>Diabetic neuropathy</topic><topic>Female</topic><topic>Glomerular filtration rate</topic><topic>Glucose monitoring</topic><topic>Health risk assessment</topic><topic>High density lipoprotein</topic><topic>Hip</topic><topic>Humans</topic><topic>Lipids</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Peripheral neuropathy</topic><topic>Population studies</topic><topic>Prevalence</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Renal function</topic><topic>Research design</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Risk management</topic><topic>Scotland - epidemiology</topic><topic>Socio-economic aspects</topic><topic>Socioeconomic Factors</topic><topic>Socioeconomics</topic><topic>Vulnerable Populations - statistics &amp; numerical data</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeyam, Anita</creatorcontrib><creatorcontrib>McGurnaghan, Stuart J</creatorcontrib><creatorcontrib>Blackbourn, Luke A K</creatorcontrib><creatorcontrib>McKnight, John M</creatorcontrib><creatorcontrib>Green, Fiona</creatorcontrib><creatorcontrib>Collier, Andrew</creatorcontrib><creatorcontrib>McKeigue, Paul M</creatorcontrib><creatorcontrib>Colhoun, Helen M</creatorcontrib><creatorcontrib>SDRNT1BIO Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeyam, Anita</au><au>McGurnaghan, Stuart J</au><au>Blackbourn, Luke A K</au><au>McKnight, John M</au><au>Green, Fiona</au><au>Collier, Andrew</au><au>McKeigue, Paul M</au><au>Colhoun, Helen M</au><aucorp>SDRNT1BIO Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2020-04</date><risdate>2020</risdate><volume>43</volume><issue>4</issue><spage>734</spage><epage>742</epage><pages>734-742</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><abstract>To assess the contemporaneous prevalence of diabetic peripheral neuropathy (DPN) in people with type 1 diabetes (T1D) in Scotland and study its cross-sectional association with risk factors and other diabetic complications. We analyzed data from a large representative sample of adults with T1D ( = 5,558). We assessed the presence of symptomatic neuropathy using the dichotomized (≥4) Michigan Neuropathy Screening Instrument Patient Questionnaire score. Logistic regression models were used to investigate associations between DPN and risk factors, as well as with other complications. The burden of DPN is substantial with 13% prevalence overall. Adjusting for attained age, diabetes duration, and sex, the odds of DPN increased mainly with waist-to-hip ratio, lipids, poor glycemic control (odds ratio 1.51 [95% CI 1.21-1.89] for levels of 75 vs. 53 mmol/mol), ever versus never smoking (1.67 [1.37-2.03]), and worse renal function (1.96 [1.03-3.74] for estimated glomerular filtration rate levels &lt;30 vs. ≥90 mL/min/1.73 m ). The odds significantly decreased with higher HDL cholesterol (0.77 [0.66-0.89] per mmol/L). Living in more deprived areas was associated with DPN (2.17 [1.78-2.65]) for more versus less deprived areas adjusted for other risk factors. Finally, individuals with prevalent DPN were much more likely than others to have other diabetes complications. Diabetic neuropathy remains substantial, particularly affecting those in the most socioeconomically deprived groups. Those with clinically manifest neuropathy also have a higher burden of other complications and elevated levels of modifiable risk factors. These data suggest that there is considerable scope to reduce neuropathy rates and narrow the socioeconomic differential by better risk factor control.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>31974100</pmid><doi>10.2337/dc19-1582</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-5220-6244</orcidid><orcidid>https://orcid.org/0000-0001-8701-0233</orcidid><orcidid>https://orcid.org/0000-0002-8345-3288</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2020-04, Vol.43 (4), p.734-742
issn 0149-5992
1935-5548
language eng
recordid cdi_proquest_miscellaneous_2344278696
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Cholesterol
Complications
Cross-Sectional Studies
Diabetes
Diabetes mellitus
Diabetes mellitus (insulin dependent)
Diabetes Mellitus, Type 1 - complications
Diabetes Mellitus, Type 1 - epidemiology
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - epidemiology
Diabetic Neuropathies - epidemiology
Diabetic Neuropathies - etiology
Diabetic neuropathy
Female
Glomerular filtration rate
Glucose monitoring
Health risk assessment
High density lipoprotein
Hip
Humans
Lipids
Male
Middle Aged
Peripheral neuropathy
Population studies
Prevalence
Regression analysis
Regression models
Renal function
Research design
Risk analysis
Risk Factors
Risk management
Scotland - epidemiology
Socio-economic aspects
Socioeconomic Factors
Socioeconomics
Vulnerable Populations - statistics & numerical data
Young Adult
title Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A39%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diabetic%20Neuropathy%20Is%20a%20Substantial%20Burden%20in%20People%20With%20Type%201%20Diabetes%20and%20Is%20Strongly%20Associated%20With%20Socioeconomic%20Disadvantage:%20A%20Population-Representative%20Study%20From%20Scotland&rft.jtitle=Diabetes%20care&rft.au=Jeyam,%20Anita&rft.aucorp=SDRNT1BIO%20Investigators&rft.date=2020-04&rft.volume=43&rft.issue=4&rft.spage=734&rft.epage=742&rft.pages=734-742&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/dc19-1582&rft_dat=%3Cproquest_cross%3E2387484234%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2387484234&rft_id=info:pmid/31974100&rfr_iscdi=true